Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium
Source
BMJ open - ISSN 2044-6055-14:3 (2024) p. 1-10
Lack of functional TCR-epitope interaction is associated with herpes zoster through reduced downstream T cell activation
Source
Cell reports - ISSN 2211-1247-43:4 (2024) p. 1-18
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts
Source
Journal of hematology and oncology - ISSN 1756-8722-17:1 (2024) p. 1-19
Antigen-specific age-related memory CD8 T cells induce and track Alzheimer’s-like neurodegeneration
Source
- (2024) p.
Rational design of a genomically humanized mouse model for dominantly inherited hearing loss, DFNA9
Source
Hearing research - ISSN 0378-5955-442 (2024) p. 1-13
Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cells
Source
Methods in cell biology-p. 143-160
Diagnosing viral infections through T cell receptor sequencing of activated CD8+ T cells
Source
The journal of infectious diseases - ISSN 0022-1899-229:2 (2024) p. 507-516
Analysis of Wilms’ tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed
Source
- () p.
Combined results of two cross-sectional surveys on the participation in clinical trials and the e-consent procedure in the landscape of haematology
Source
Clinics and practice - ISSN 2039-7275-13:6 (2023) p. 1520-1531
Decentralised, point-of-care CAR-T for multiple myeloma
Source
The lancet oncology - ISSN 1470-2045-24:8 (2023) p. 828-830